- Filed
- Aug 30, 2023 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2024 · Aug 23, 2023 | 24.34M sh |
| Shares Diluted | Q2 2024 · Jul 31, 2023 | 24.19M sh |
| Shares Diluted | Q2 2024 · Jul 31, 2023 | 24.16M sh |
| Shares Diluted | Q2 2024 · Jul 31, 2022 | 23.92M sh |
| Shares Diluted | Q2 2024 · Jul 31, 2022 | 24.46M sh |
| Stock Repurchased | Q2 2024 · Jul 31, 2023 | $0 |
| Stock Repurchased | Q2 2024 · Jul 31, 2022 | $71.7M |
| Capex | Q2 2024 · Jul 31, 2023 | $30.03M |
| Capex | Q2 2024 · Jul 31, 2022 | $35.15M |
| Operating Cash Flow | Q2 2024 · Jul 31, 2023 | $3.61M |
| Operating Cash Flow | Q2 2024 · Jul 31, 2022 | $62.83M |
| Long Term Debt | Q2 2024 · Jul 31, 2023 | $639.95M |
| Long Term Debt | Q2 2024 · Jan 31, 2023 | $636.08M |
| Short Term Debt | Q2 2024 · Jul 31, 2023 | $9.04M |
| Short Term Debt | Q2 2024 · Jan 31, 2023 | $937K |
| Cash And Equivalents | Q2 2024 · Jul 31, 2023 | $8.56M |
| Cash And Equivalents | Q2 2024 · Jan 31, 2023 | $19.53M |
| Stockholders Equity | Q2 2024 · Jul 31, 2023 | $439.32M |
| Stockholders Equity | Q2 2024 · Apr 30, 2023 | $469.51M |
| Stockholders Equity | Q2 2024 · Jan 31, 2023 | $502.41M |
| Stockholders Equity | Q2 2024 · Jul 31, 2022 | $559.88M |
| Stockholders Equity | Q2 2024 · Apr 30, 2022 | $554.39M |
| Stockholders Equity | Q2 2024 · Jan 31, 2022 | $614.82M |
| Current Liabilities | Q2 2024 · Jul 31, 2023 | $247.75M |
| Current Liabilities | Q2 2024 · Jan 31, 2023 | $222.36M |
| Total Liabilities | Q2 2024 · Jul 31, 2023 | $1.26B |
| Total Liabilities | Q2 2024 · Jan 31, 2023 | $1.21B |
| Current Assets | Q2 2024 · Jul 31, 2023 | $813.66M |
| Current Assets | Q2 2024 · Jan 31, 2023 | $831.1M |
| Total Assets | Q2 2024 · Jul 31, 2023 | $1.7B |
| Total Assets | Q2 2024 · Jan 31, 2023 | $1.72B |
| Total Assets | Q2 2024 · Jul 31, 2022 | $1.75B |
| Eps Diluted | Q2 2024 · Jul 31, 2023 | −$1.39 |
| Eps Diluted | Q2 2024 · Jul 31, 2023 | −$2.85 |
| Eps Diluted | Q2 2024 · Jul 31, 2022 | $0.09 |
| Eps Diluted | Q2 2024 · Jul 31, 2022 | $0.34 |
| Eps Basic | Q2 2024 · Jul 31, 2023 | −$1.39 |
| Eps Basic | Q2 2024 · Jul 31, 2023 | −$2.85 |
| Eps Basic | Q2 2024 · Jul 31, 2022 | $0.09 |
| Eps Basic | Q2 2024 · Jul 31, 2022 | $0.34 |
| Sga Expense | Q2 2024 · Jul 31, 2023 | $134.97M |
| Sga Expense | Q2 2024 · Jul 31, 2023 | $264.21M |
| Sga Expense | Q2 2024 · Jul 31, 2022 | $130.14M |
| Sga Expense | Q2 2024 · Jul 31, 2022 | $262.93M |
| Net Income | Q2 2024 · Jul 31, 2023 | −$33.52M |
| Net Income | Q2 2024 · Jul 31, 2023 | −$68.9M |
| Net Income | Q2 2024 · Apr 30, 2023 | −$35.38M |
| Net Income | Q2 2024 · Jul 31, 2022 | $2.13M |
| Net Income | Q2 2024 · Jul 31, 2022 | $8.35M |
| Net Income | Q2 2024 · Apr 30, 2022 | $6.22M |
| Operating Income | Q2 2024 · Jul 31, 2023 | −$15.36M |
| Operating Income | Q2 2024 · Jul 31, 2023 | −$36.06M |
| Operating Income | Q2 2024 · Jul 31, 2022 | $8.03M |
| Operating Income | Q2 2024 · Jul 31, 2022 | $21.96M |
| Cost Of Revenue | Q2 2024 · Jul 31, 2023 | $153.99M |
| Cost Of Revenue | Q2 2024 · Jul 31, 2023 | $301.92M |
| Cost Of Revenue | Q2 2024 · Jul 31, 2022 | $182.72M |
| Cost Of Revenue | Q2 2024 · Jul 31, 2022 | $361.1M |
| Revenue | Q2 2024 · Jul 31, 2023 | $243.65M |
| Revenue | Q2 2024 · Jul 31, 2023 | $466.19M |
| Revenue | Q2 2024 · Jul 31, 2022 | $279.51M |
| Revenue | Q2 2024 · Jul 31, 2022 | $551.78M |